Literature DB >> 19559607

An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.

Dalip Kumar1, Swapna Sundaree, Emmanuel O Johnson, Kavita Shah.   

Abstract

A facile, convenient and high yielding synthesis of a series of novel 5-(3'-indolyl)-2-(substituted)-1,3,4-oxadiazoles from readily available starting materials has been described. The key step of this protocol is oxidative cyclization of N-acylhydrazones 1 using [bis(trifluoroacetoxy)iodo]benzene under solvent-free condition. The 5-(3'-indolyl)-2-(substituted)-1,3,4-oxadiazoles were screened for their in vitro anticancer activity against various human cancer cell lines. Compounds 3c, 3d and 3j exhibited potent cytotoxicity (IC(50) approximately 1microM) and selectivity against human cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559607     DOI: 10.1016/j.bmcl.2009.03.172

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells.

Authors:  Zhen-yu Shi; Yong-qiang Li; Yu-hua Kang; Guo-qiang Hu; Chao-shen Huang-fu; Jin-Bo Deng; Bin Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Synthesis, X-ray crystal structures and optical properties of novel substituted pyrazoly 1,3,4-oxadiazole derivatives.

Authors:  Hong-Shui Lv; Yong-Sheng Xie; Wei-Yong Liu; Zhong-Liang Gong; Bao-Xiang Zhao
Journal:  J Fluoresc       Date:  2011-03-05       Impact factor: 2.217

3.  Synthesis, fluorescence properties and theoretical calculations of novel stilbene derivatives based on 1,3,4-oxadiazole bearing anthracene core.

Authors:  Xinwei Li; Huixiong Lu; Daohang He; Chun Luo; Jianjun Huang
Journal:  J Fluoresc       Date:  2013-05-12       Impact factor: 2.217

4.  Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.

Authors:  Sultan Nacak Baytas; Nazan Inceler; Akin Yilmaz; Abdurrahman Olgac; Sevda Menevse; Erden Banoglu; Ernest Hamel; Roberta Bortolozzi; Giampietro Viola
Journal:  Bioorg Med Chem       Date:  2014-04-20       Impact factor: 3.641

5.  Synthesis and In Vitro Antimicrobial Evaluation of New 1,3,4-Oxadiazoles Bearing 5-Chloro-2-methoxyphenyl Moiety.

Authors:  Basavapatna N Prasanna Kumar; Kikkeri N Mohana; Lingappa Mallesha; Kikkeri P Harish
Journal:  Int J Med Chem       Date:  2013-03-31

6.  Study on the synthesis of novel 5-substituted 2-[2-(pyridyl)ethenyl]-1,3,4-oxadiazoles and their acid-base interactions.

Authors:  Agnieszka Kudelko; Karolina Jasiak; Krzysztof Ejsmont
Journal:  Monatsh Chem       Date:  2014-12-20       Impact factor: 1.451

7.  Trimethoxy-benzaldehyde levofloxacin hydrazone inducing the growth arrest and apoptosis of human hepatocarcinoma cells.

Authors:  Jin-Ping Sun; Zhen-Yu Shi; Shi-Meng Liu; Yu-Hua Kang; Guo-Qiang Hu; Chao-Shen Huangfu; Jin-Bo Deng; Bin Liu
Journal:  Cancer Cell Int       Date:  2013-07-02       Impact factor: 5.722

8.  One-pot synthesis and in-vitro anticancer evaluation of 5-(2'-indolyl)thiazoles.

Authors:  Buchi Reddy Vaddula; Mukund P Tantak; Rachana Sadana; Michael A Gonzalez; Dalip Kumar
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379

9.  Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells.

Authors:  Chakrabhavi Dhananjaya Mohan; Nirvanappa C Anilkumar; Shobith Rangappa; Muthu K Shanmugam; Srishti Mishra; Arunachalam Chinnathambi; Sulaiman Ali Alharbi; Atanu Bhattacharjee; Gautam Sethi; Alan Prem Kumar; Kanchugarakoppal S Rangappa
Journal:  Front Oncol       Date:  2018-03-19       Impact factor: 6.244

10.  Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.

Authors:  Ahmet Özdemir; Belgin Sever; Mehlika Dilek Altıntop; Halide Edip Temel; Özlem Atlı; Merve Baysal; Fatih Demirci
Journal:  Molecules       Date:  2017-07-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.